Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

U G Lempert

Showing results (1-10 of 13) with videos related to

Pageof 2
Sort By:
Zeitschrift Fur Rheumatologie|April 19, 2000
[Inflammation mediated osteopenia (IMO): therapeutic effect of D-hormone and the role of cytokines]S H Scharla, U G Lempert, I Kamilli
Hormone and Metabolic Research = Hormon- Und Stoffwechselforschung = Hormones Et Metabolisme|February 1, 1993
Bone loss in experimental diabetes. Comparison with the model of inflammation mediated osteopeniaD Hadjidakis, U G Lempert, H W Minne, et al.
Experimental and Clinical Endocrinology & Diabetes : Official Journal, German Society of Endocrinology [And] German Diabetes Association|December 28, 1999
Prevalence of low bone mass and endocrine disorders in hip fracture patients in Southern GermanyS H Scharla, S Wolf, R Düll, et al.
Bone and Mineral|May 1, 1991
Influence of parathyroidectomy, 1,25-dihydroxyvitamin D3 and high dietary calcium intake on demineralized bone matrix powder-induced bone formation in the ratU G Lempert, S H Scharla, H W Minne, et al.
Bone and Mineral|September 1, 1989
1,25-Dihydroxyvitamin D3 prevents the decrease of bone mineral appositional rate in rats with inflammation-mediated osteopenia (IMO)U G Lempert, H W Minne, B Albrecht, et al.
Bone and Mineral|May 1, 1989
The hypercalcemic Walker carcinosarcoma 256 of the rat causes an increase in serum 1,25-dihydroxyvitamin D3S H Scharla, H W Minne, C Oswald, et al.
Calcified Tissue International|April 1, 1991
Inflammation-mediated osteopenia (IMO): no change in bone resorption during its developmentU G Lempert, H W Minne, H Fleisch, et al.
Bone and Mineral|November 1, 1989
Antiestrogen and antiandrogen administration reduce bone mass in the ratS Feldmann, H W Minne, S Parvizi, et al.
Acta Endocrinologica|December 1, 1992
Studies on regulation of insulin-like growth factor binding protein (IGFBP)-3 and IGFBP-4 production in human bone cellsS Mohan, D D Strong, U G Lempert, et al.
Experimental and Clinical Endocrinology|January 1, 1994
Bone mineral density and calcium regulating hormones in patients with inflammatory bowel disease (Crohn's disease and ulcerative colitis)S H Scharla, H W Minne, U G Lempert, et al.
Pageof 2

Showing results (1-10 of 13) with videos related to

Sort By:
Pageof 2
Zeitschrift Fur Rheumatologie|April 19, 2000
[Inflammation mediated osteopenia (IMO): therapeutic effect of D-hormone and the role of cytokines]S H Scharla, U G Lempert, I Kamilli
Hormone and Metabolic Research = Hormon- Und Stoffwechselforschung = Hormones Et Metabolisme|February 1, 1993
Bone loss in experimental diabetes. Comparison with the model of inflammation mediated osteopeniaD Hadjidakis, U G Lempert, H W Minne, et al.
Experimental and Clinical Endocrinology & Diabetes : Official Journal, German Society of Endocrinology [And] German Diabetes Association|December 28, 1999
Prevalence of low bone mass and endocrine disorders in hip fracture patients in Southern GermanyS H Scharla, S Wolf, R Düll, et al.
Bone and Mineral|May 1, 1991
Influence of parathyroidectomy, 1,25-dihydroxyvitamin D3 and high dietary calcium intake on demineralized bone matrix powder-induced bone formation in the ratU G Lempert, S H Scharla, H W Minne, et al.
Bone and Mineral|September 1, 1989
1,25-Dihydroxyvitamin D3 prevents the decrease of bone mineral appositional rate in rats with inflammation-mediated osteopenia (IMO)U G Lempert, H W Minne, B Albrecht, et al.
Bone and Mineral|May 1, 1989
The hypercalcemic Walker carcinosarcoma 256 of the rat causes an increase in serum 1,25-dihydroxyvitamin D3S H Scharla, H W Minne, C Oswald, et al.
Calcified Tissue International|April 1, 1991
Inflammation-mediated osteopenia (IMO): no change in bone resorption during its developmentU G Lempert, H W Minne, H Fleisch, et al.
Bone and Mineral|November 1, 1989
Antiestrogen and antiandrogen administration reduce bone mass in the ratS Feldmann, H W Minne, S Parvizi, et al.
Acta Endocrinologica|December 1, 1992
Studies on regulation of insulin-like growth factor binding protein (IGFBP)-3 and IGFBP-4 production in human bone cellsS Mohan, D D Strong, U G Lempert, et al.
Experimental and Clinical Endocrinology|January 1, 1994
Bone mineral density and calcium regulating hormones in patients with inflammatory bowel disease (Crohn's disease and ulcerative colitis)S H Scharla, H W Minne, U G Lempert, et al.
Pageof 2